v3.26.3
Collaborative, Licensing and Other Arrangements - Schedule of Funding Expenses (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Research and Development Arrangement, Contract to Perform for Others        
Research and development expense $ 660,784 $ 523,662 $ 1,814,288 $ 1,530,445
Amgen, Inc        
Research and Development Arrangement, Contract to Perform for Others        
BeOne’s portion of the development funding 12,204 59,325 130,070 152,040
Less: Amortization of research and development cost share liability 6,182 29,275 64,345 74,844
Research and development expense $ 6,022 $ 30,050 $ 65,725 $ 77,196